Details for New Drug Application (NDA): 050596
✉ Email this page to a colleague
NDA 050596 describes CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, which is a drug marketed by Sterimax and is included in one NDA. Additional details are available on the CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER profile page.
The generic ingredient in CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is cefotaxime sodium. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cefotaxime sodium profile page.
The generic ingredient in CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is cefotaxime sodium. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cefotaxime sodium profile page.
Summary for 050596
| Tradename: | CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER |
| Applicant: | Sterimax |
| Ingredient: | cefotaxime sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050596
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 20MG BASE/ML | ||||
| Approval Date: | May 20, 1985 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 20MG BASE/ML | ||||
| Approval Date: | May 20, 1985 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 40MG BASE/ML | ||||
| Approval Date: | May 20, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
